News/ News/ R&D BMS confirms Taisho’s $1.6bn offer for UPSA Phil Taylor BMS, Taisho Pharma, UPSA 0 Comment After protracted speculation, Bristol-Myers Squibb has confirmed it plans to divest its French over-the-counter (OTC) medicines business UPSA Share X BMS confirms Taisho’s $1.6bn offer for UPSA https://pharmaphorum.com/news/bms-confirms-taishos-1-6bn-offer-for-upsa/
